Advances in Systemic Therapy & Encore Presentations - Joint Session With ENSCCA

Friday, September 4, 2026 2:20 PM to 4:00 PM · 1 hr. 40 min. (CET)
Scientific Programme

Information

Chaired by Angela Lamarca & Grainne O'Kane

14:25-14:40 - Chiara Braconi

Novel approaches in CCA (with a focus on HER2 and KRAS inhibition)

14:40-14:50 - Anna Saborowski

Updates in FGFR2 fusion target for CCA

14:50-15:00 - John Bridgewater

Peri-operative approaches to cholangiocarcinoma

15:00-15:10 - David Pinato

Response in the era of immunotherapy

15:10-15:30 - Q&A

15:30-15:40 - Mohamed Bouattour (encore presentation)

Tumour response analyses by RECIST v1.1 and mRECIST in the Phase 3 EMERALD-3 study of tremelimumab plus durvalumab with or without lenvatinib plus transarterial chemoembolisation (TACE) in embolisation-eligible hepatocellular carcinoma (eeHCC)

15:40 - 16:00 - Q&A